Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer

Antioxidants and Redox Signaling

Volumn 26, Issue 2, 2017, Pages 84-103

  Rohlenova, Katerina ^a   Sachaphibulkij, Karishma ^a   Stursa, Jan ^a,b,c   Bezawork Geleta, Ayenachew ^a   Blecha, Jan ^a   Endaya, Berwini ^a   Werner, Lukas ^c   Cerny, Jiri ^a   Zobalova, Renata ^a   Goodwin, Jacob ^a   Spacek, Tomas ^d   Alizadeh Pesdar, Elham ^a   Yan, Bing ^a   Nguyen, Maria Nga ^a   Vondrusova, Magdalena ^a   Sobol, Margaryta ^e   Jezek, Petr ^d   Hozak, Pavel ^e   Truksa, Jaroslav ^a   Rohlena, Jakub ^a   Dong, Lan Feng ^a   Neuzil, Jiri ^a   more..

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d Institute of Physiology   (Czech Republic)

^e INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TAMOXIFEN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MULTIENZYME COMPLEX; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SENSITIVITY ANALYSIS; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CELL RESPIRATION; CHEMISTRY; CONFORMATION; DRUG EFFECTS; FEMALE; IC50; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR MODEL; MOLECULARLY TARGETED THERAPY; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOMARKERS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL RESPIRATION; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR TARGETED THERAPY; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RECEPTOR, ERBB-2; TAMOXIFEN;

EID: 85008884183     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6677     Document Type: Article

References (60)

1. Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, and Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 32: 529-539, 2008.
2. Althoff T, Mills DJ, Popot JL, and Kuhlbrandt W. Arrangement of electron transport chain components in bovine mitochondrial supercomplex I1III2IV1. EMBO J 30: 4652-4664, 2011.
3. Birsoy K, Wang T, Chen WW, Freinkman E, Abu-Remaileh M, and Sabatini DM. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162: 540-551, 2015.
4. Cerny J, Jurecka P, Hobza P, and Valdes H. Resolution of identity density functional theory augmented with an empirical dispersion term (RI-DFT-D): A promising tool for studying isolated small peptides. J Phys Chem A 111: 1146-1154, 2007.
5. Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, and Giordano SH. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review. J Clin Oncol 28: 92-98, 2010.
6. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, and Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64: 252-271, 2014.
7. Ding Y, Liu Z, Desai S, Zhao Y, Liu H, Pannell LK, Yi H, Wright ER, Owen LB, Dean-Colomb W, Fodstad O, Lu J, LeDoux SP, Wilson GL, and Tan M. Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun 3: 1271, 2012.
8. Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, Goodwin J, Brunk UT, Witting PK, Moreno-Sanchez R, Scheffler IE, Ralph SJ, and Neuzil J. Suppression of tumor growth in vivo by the mitocan alpha-Tocopheryl succinate requires respiratory complex II. Clin Cancer Res 15: 1593-1600, 2009.
9. Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Marin-Hernandez A, Hernandez-Esquivel L, Rodriguez-Enriquez S, Stursa J, Witting PK, Stantic B, Rohlena J, Truksa J, Kluckova K, Dyason JC, Ledvina M, Salvatore BA, Moreno-Sanchez R, Coster MJ, Ralph SJ, Smith RA, and Neuzil J. Mitochondrial targeting of vitamin E succinate enhances its pro-Apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem 286: 3717-3728, 2011.
10. Dong LF, Jameson VJ, Tilly D, Prochazka L, Rohlena J, Valis K, Truksa J, Zobalova R, Mahdavian E, Kluckova K, Stantic M, Stursa J, Freeman R, Witting PK, Norberg E, Goodwin J, Salvatore BA, Novotna J, Turanek J, Ledvina M, Hozak P, Zhivotovsky B, Coster MJ, Ralph SJ, Smith RA, and Neuzil J. Mitochondrial targeting of alphatocopheryl succinate enhances its pro-Apoptotic efficacy: A new paradigm for effective cancer therapy. Free Radic Biol Med 50: 1546-1555, 2011.
11. Dong LF, Low P, Dyason JC, Wang XF, Prochazka L, Witting PK, Freeman R, Swettenham E, Valis K, Liu J, Zobalova R, Turanek J, Spitz DR, Domann FE, Scheffler IE, Ralph SJ, and Neuzil J. Alpha-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 27: 4324-4335, 2008.
12. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, and Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
13. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, and Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 89: 10578-10582, 1992.
14. Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL, Wargo JA, Song JS, Fisher DE, Arany Z, and Widlund HR. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 23: 302-315, 2013.
15. Kim EM, Park JK, Hwang SG, Kim WJ, Liu ZG, Kang SW, and Um HD. Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory Complex-I activity via Bcl-2 family proteins. Oncotarget 5: 8452-8465, 2014.
16. Kluckova K, Dong LF, Bajzikova M, Rohlena J, and Neuzil J. Evaluation of respiration of mitochondria in cancer cells exposed to mitochondria-Targeted agents. Methods Mol Biol 1265: 181-194, 2015.
17. Kluckova K, Sticha M, Cerny J, Mracek T, Dong L, Drahota Z, Gottlieb E, Neuzil J, and Rohlena J. Ubiquinonebinding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation. Cell Death Dis 6: e1749, 2015.
18. Kordes S, Pollak MN, Zwinderman AH, Mathot RA, Weterman MJ, Beeker A, Punt CJ, Richel DJ, and Wilmink JW. Metformin in patients with advanced pancreatic cancer: A double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 16: 839-847, 2015.
19. Kussmaul L and Hirst J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A 103: 7607-7612, 2006.
20. Kwong JQ, Henning MS, Starkov AA, and Manfredi G. The mitochondrial respiratory chain is a modulator of apoptosis. J Cell Biol 179: 1163-1177, 2007.
21. Lapuente-Brun E, Moreno-Loshuertos R, Acin-Perez R, Latorre-Pellicer A, Colas C, Balsa E, Perales-Clemente E, Quiros PM, Calvo E, Rodriguez-Hernandez MA, Navas P, Cruz R, Carracedo A, Lopez-Otin C, Perez-Martos A, Fernandez-Silva P, Fernandez-Vizarra E, and Enriquez JA. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 340: 1567-1570, 2013.
22. LeBleu VS, OConnell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A, Domingos Chinen LT, Rocha RM, Asara JM, and Kalluri R. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16: 992-1003, 1-15, 2014.
23. Lega IC, Austin PC, Gruneir A, Goodwin PJ, Rochon PA, and Lipscombe LL. Association between metformin therapy and mortality after breast cancer: A population-based study. Diabetes Care 36: 3018-3026, 2013.
24. Maranzana E, Barbero G, Falasca AI, Lenaz G, and Genova ML. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid Redox Signal 19: 1469-1480, 2013.
25. Moreira PI, Custodio J, Moreno A, Oliveira CR, and Santos MS. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J Biol Chem 281: 10143-10152, 2006.
26. Moreno-Lastres D, Fontanesi F, Garcia-Consuegra I, Martin MA, Arenas J, Barrientos A, and Ugalde C. Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab 15: 324-335, 2012.
27. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, and Olson AJ. AutoDock4 and Auto-DockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791, 2009.
28. Murphy MP and Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47: 629-656, 2007.
29. Neuzil J, Weber T, Gellert N, and Weber C. Selective cancer cell killing by alpha-Tocopheryl succinate. Br J Cancer 84: 87-89, 2001.
30. Neuzil J, Weber T, Schroder A, Lu M, Ostermann G, Gellert N, Mayne GC, Olejnicka B, Negre-Salvayre A, Sticha M, Coffey RJ, and Weber C. Induction of cancer cell apoptosis by alpha-Tocopheryl succinate: molecular pathways and structural requirements. FASEB J 15: 403-415, 2001.
31. Pesta D and Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810: 25-58, 2012.
32. Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, De-Berardinis RJ, and Morrison SJ. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527: 186-191, 2015.
33. Prochazka L, Koudelka S, Dong LF, Stursa J, Goodwin J, Neca J, Slavik J, Ciganek M, Masek J, Kluckova K, Nguyen M, Turanek J, and Neuzil J. Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to alpha-Tocopheryl succinate. Apoptosis 18: 286-299, 2013.
34. Pulaski BA and Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol Chapter 20: Unit 20 2, 2001.
35. Reni M, Dugnani E, Cereda S, Belli C, Balzano G, Nicoletti R, Liberati D, Pasquale V, Scavini M, Maggiora P, Sordi V, Lampasona V, Ceraulo D, Di Terlizzi G, Doglioni C, Falconi M, and Piemonti L. (Ir)relevance of metformin treatment in patients with metastatic pancreatic cancer: An open-label, randomized phase 2 trial. Clin Cancer Res 22: 1076-1085, 2016.
36. Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Korbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, Patzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, Hoth M, Bastian BC, Vogt T, and Herlyn M. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 23: 811-825, 2013.
37. Rohlena J, Dong LF, Kluckova K, Zobalova R, Goodwin J, Tilly D, Stursa J, Pecinova A, Philimonenko A, Hozak P, Banerjee J, Ledvina M, Sen CK, Houstek J, Coster MJ, and Neuzil J. Mitochondrially targeted alpha-Tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing. Antioxid Redox Signal 15: 2923-2935, 2011.
38. Rohlena J, Dong LF, and Neuzil J. Targeting the mitochondrial electron transport chain complexes for the induction of apoptosis and cancer treatment. Curr Pharm Biotechnol 14: 377-389, 2013.
39. Rohlena J, Dong LF, Ralph SJ, and Neuzil J. Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid Redox Signal 15: 2951-2974, 2011.
40. Rohlenova K, Neuzil J, and Rohlena J. The role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria. Biol Chem 397: 607-615, 2016.
41. Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, Le-Boeuf SE, Gay LJ, Yagi T, and Felding-Habermann B. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 123: 1068-1081, 2013.
42. Saura C, Bendell J, Jerusalem G, Su S, Ru Q, De Buck S, Mills D, Ruquet S, Bosch A, Urruticoechea A, Beck JT, Di Tomaso E, Sternberg DW, Massacesi C, Hirawat S, Dirix L, and Baselga J. Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy. Clin Cancer Res 20: 1935-1945, 2014.
43. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, and Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461: 109-113, 2009.
44. Siegel RL, Miller KD, and Jemal A. Cancer statistics, 2015. CA Cancer J Clin 65: 5-29, 2015.
45. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, and McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
46. Soderberg K, Mascarello JT, Breen GA, and Scheffler IE. Respiration-deficient Chinese hamster cell mutants: genetic characterization. Somatic Cell Genet 5: 225-240, 1979.
47. Soderberg KL, Ditta GS, and Scheffler IE. Mammalian cells with defective mitochondrial functions: A Chinese hamster mutant cell line lacking succinate dehydrogenase activity. Cell 10: 697-702, 1977.
48. Spinazzi M, Casarin A, Pertegato V, Salviati L, and Angelini C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7: 1235-1246, 2012.
49. Stapelberg M, Zobalova R, Nguyen MN, Walker T, Stantic M, Goodwin J, Pasdar EA, Thai T, Prokopova K, Yan B, Hall S, de Pennington N, Thomas SR, Grant G, Stursa J, Bajzikova M, Meedeniya AC, Truksa J, Ralph SJ, Ansorge O, Dong LF, and Neuzil J. Indoleamine-2, 3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans. Free Radic Biol Med 67: 41-50, 2014.
50. Sullivan LB, Gui DY, Hosios AM, Bush LN, Freinkman E, and Vander Heiden MG. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162: 552-563, 2015.
51. Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, Bajzikova M, Kovarova J, Peterka M, Yan B, Pesdar EA, Sobol M, Filimonenko A, Stuart S, Vondrusova M, Kluckova K, Sachaphibulkij K, Rohlena J, Hozak P, Truksa J, Eccles D, Haupt LM, Griffiths LR, Neuzil J, and Berridge MV. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab 21: 81-94, 2015.
52. Treberg JR, Quinlan CL, and Brand MD. Evidence for two sites of superoxide production by mitochondrial NADHubiquinone oxidoreductase (complex I). J Biol Chem 286: 27103-27110, 2011.
53. Truksa J, Dong LF, Rohlena J, Stursa J, Vondrusova M, Goodwin J, Nguyen M, Kluckova K, Rychtarcikova Z, Lettlova S, Spacilova J, Stapelberg M, Zoratti M, and Neuzil J. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis. Antioxid Redox Signal 22: 883-900, 2015.
54. Viale A, Corti D, and Draetta GF. Tumors and mitochondrial respiration: A neglected connection. Cancer Res 75: 3687-3691, 2015.
55. Viale A, Pettazzoni P, Lyssiotis CA, Ying H, Sanchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V, Kost-Alimova M, Muller F, Colla S, Nezi L, Genovese G, Deem AK, Kapoor A, Yao W, Brunetto E, Kang Y, Yuan M, Asara JM, Wang YA, Heffernan TP, Kimmelman AC, Wang H, Fleming JB, Cantley LC, DePinho RA, and Draetta GF. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514: 628-632, 2014.
56. Voss NR and Gerstein M. 3V: cavity, channel and cleft volume calculator and extractor. Nucleic Acids Res 38: W555-W562, 2010.
57. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, and Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107: 8788-8793, 2010.
58. Wolf DA. Is reliance on mitochondrial respiration a chink in the armor of therapy-resistant cancer? Cancer Cell 26: 788-795, 2014.
59. Zhang Q, Raje V, Yakovlev VA, Yacoub A, Szczepanek K, Meier J, Derecka M, Chen Q, Hu Y, Sisler J, Hamed H, Lesnefsky EJ, Valerie K, Dent P, and Larner AC. Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem 288: 31280-31288, 2013.
60. Zickermann V, Wirth C, Nasiri H, Siegmund K, Schwalbe H, Hunte C, and Brandt U. Structural biology. Mechanistic insight from the crystal structure of mitochondrial complex I. Science 347: 44-49, 2015.